Reporting owner · CIK 0001808744

OrbiMed Genesis GP LLC

Visual SEC Form 4 history across 2 companies, 14 transactions and 2 filings.

DIRElectra Therapeutics, Inc.
Open-market mix
Latest filingSep 23, 2026, 09:29 PM
Filings2Form 4 records
Buying$22M6 purchases
Selling$00 sales
Net value$22MBuys minus sells
Companies24 securities
Most recentSep 21, 2026unknown

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

6 observations · Sep 21, 2026 – Sep 21, 2026. Window ends at the latest available report, not today.

Selected observation · Sep 21, 20261,758,279 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Sep 21, 20262,002,310Sep 23, 2026View transaction
Sep 21, 20263,090,244Sep 23, 2026View transaction
Sep 21, 20264,793,558Sep 23, 2026View transaction
Sep 21, 20265,126,891Sep 23, 2026View transaction
Sep 21, 2026758,279Sep 23, 2026View transaction
Sep 21, 20261,758,279Sep 23, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-54Feb 252Sep 26

Net value flow

Buys minus sells

Feb 25
$2M
Sep 26
$20M

Transaction texture

Ownership and ticket size

Average P/S size$3.7M
Median P/S size$776K
Direct0
Indirect14
Sep 21, 2026unknown

Filing-only signals

Deterministic matches in this insider's history

Cluster Buypattern4Director Buyrole4Large Buysize1Repeat Buyerpattern310% Owner Buyrole4

Latest Form 4 facts

Quick context from source filings

Latest transaction

buy at Electra Therapeutics, Inc. on Sep 21, 2026 valued at $15,000,000.

Review SEC filing
Latest buy

buy at Electra Therapeutics, Inc. on Sep 21, 2026 valued at $15,000,000.

Review SEC filing
Latest sale

No open-market insider sale is available.

Associated companies

Visual map of known reporting history

Electra Therapeutics, Inc.ETRA · 10 transactions · latest Sep 23, 2026, 09:29 PMMBX Biosciences, Inc.MBX · 4 transactions · latest Feb 19, 2025, 10:52 PM

Latest insider transactions

Form 4 filings from available history. Click any column to sort; click it again to flip the order.

OrbiMed Genesis GP LLC transactions
IDTickerInsiderRoleTypeSharesValueCodeFiledTrans date
#228543ETRAOrbiMed Genesis GP LLC
DIR
unknown758k$0C09/2309/21
#228542ETRAOrbiMed Genesis GP LLC
DIR
unknown1.70M$0C09/2309/21
#228541ETRAOrbiMed Genesis GP LLC
DIR
unknown1.08M$0C09/2309/21
#228540ETRAOrbiMed Genesis GP LLC
DIR
unknown2.00M$0C09/2309/21
#228539ETRAOrbiMed Genesis GP LLC
DIR
buy1.00M$1.50BP09/2309/21
#228538ETRAOrbiMed Genesis GP LLC
DIR
unknown758k—C09/2309/21
#228537ETRAOrbiMed Genesis GP LLC
DIR
buy333k$499MP09/2309/21
#228536ETRAOrbiMed Genesis GP LLC
DIR
unknown1.70M—C09/2309/21
#228535ETRAOrbiMed Genesis GP LLC
DIR
unknown1.08M—C09/2309/21
#228534ETRAOrbiMed Genesis GP LLC
DIR
unknown2.00M—C09/2309/21

OrbiMed Genesis GP LLC Insider Activity FAQ

SEC Form 4 context

Who is OrbiMed Genesis GP LLC?

OrbiMed Genesis GP LLC is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001808744.

Which companies has OrbiMed Genesis GP LLC reported transactions for?

Electra Therapeutics, Inc., MBX Biosciences, Inc.

When was OrbiMed Genesis GP LLC's latest insider buy?

buy at Electra Therapeutics, Inc. on Sep 21, 2026 valued at $15,000,000.

When was OrbiMed Genesis GP LLC's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.